ATAK
DEAD

Serial Number

88450728

Owner

Myeloid Therapeutics, Inc.

Attorney

Aaron Hendelman

Filing Date

May 29, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ATAK Trademark

Serial Number: 88450728

ATAK is a trademark filed by Myeloid Therapeutics, Inc. on May 29, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Myeloid Therapeutics, Inc. (3 trademarks)

300 Technology Square, Suite 203
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

May 29, 2019

Registration Date

Not Registered

Goods & Services

biological and medicinal preparations and substances for the prevention and treatment of oncological and immune system related diseases and disorders, and for use with transplantation; biological and medicinal preparations and substances for the prevention and treatment of cancer and infectious diseases; anti-cancer preparations; all of the aforementioned goods in relation to cell and gene therapy methods

medical services for the prevention and treatment of cancer and autoimmune and infectious diseases; medical services for transplantation; medical services and providing information in the fields of cancer, oncology, autoimmune and infectious diseases, and transplantation; all of the aforementioned services in relation to cell and gene therapy methods

providing medical and scientific research information in the fields of cancer, oncology, autoimmune and infectious diseases, and transplantation; medical and scientific research services in the fields of the prevention and treatment of cancer, oncology, autoimmune and infectious diseases, and transplantation; providing laboratory research services in the fields of cancer biology, cancer, oncology, autoimmune and infectious diseases, and transplantation; all of the aforementioned services in relation to cell and gene therapy methods

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 1, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 1, 2024 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 19, 2023 GNFN
FINAL REFUSAL E-MAILED
Oct 19, 2023 GNFR
FINAL REFUSAL WRITTEN
Oct 19, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 11, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 11, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 21, 2023 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 29, 2023 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 22, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 14, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 20, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 20, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 16, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 16, 2020 GNSL
SUSPENSION LETTER WRITTEN
Mar 16, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 24, 2020 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 24, 2020 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 24, 2020 CHAN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 24, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 24, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 24, 2020 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 22, 2019 GNRN
NON-FINAL ACTION E-MAILED
Aug 22, 2019 GNRT
NON-FINAL ACTION WRITTEN
Aug 22, 2019 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 13, 2019 NWOS
NEW APPLICATION ENTERED
Jun 1, 2019 NWAP